|Legal Status||Not Controlled|
No legal implications
Veterinary anthelminthic for the treatment of nematode infestations in cattle, sheep and pigs. Levamisole presents as both an oral preparation and an injection. Some oral preparations contain other active ingredients.
Single oral doses are generally well tolerated. Around 1% of patients report nausea and vomiting. Chronic ingestion may result in agranulocytosis and other haematological complications. Accidental self injection of veterinary products may cause a mild local reaction. The main risk is that of extraneous bacterial infection. Levamisole rarely causes symptoms in humans after a single exposure.
|Short Term Effects||
Adverse effects after a single ingestion are uncommon but may include may include nausea, vomiting, diarrhoea, abdominal pain, dizziness and headache. Chronic ingestion may cause hypersensitivity reactions such as fever, a flu like syndrome, arthralgia, myalgia, skin rashes and cutaneous vasculitis. Other effects from chronic exposure may include headache, insomnia, convulsions, haematological abnormalities; agranulocytosis, leucopenia and thrombocytopenia; taste disturbance and GI disturbances.
|Long Term Effects||
Hepatotoxicity is a possible complication with chronic use (Papageorgiou P et al, 1982, Bulugahapitiya DTD, 1997). Encephalopathy (El Kallab et al, 2003) and leucoencephalopathy have also been reported (Lucia P et al, 1996)
Identified in Poland: • N-(2-(dimethylamino)cyclohexyl)-N-methylbenzo[d][1,3]dioxole-5-carboxamide (3,4-methylenedioxy-U-47700)a NPS Opioid
There have been recent deaths and hospitalisations relating to substance use at festivals.: Be aware that over the past few years there has been an increase in the dosage and purity of substances available, in particular MDMA ‘Ecstasy’ pills. Increased purity and dosage means an increase in potential for adverse effects. Pills and powders etc.. may not contain what is intended, different substances have different doses,effects, time of onset and duration. Where WEDINOS have tested pressed pills; the result relates only to the samples analysed and cannot be used to indicate the contents, profile or quality of a wider batch of the substance. This is always the case despite pills having the same logo, shape size and colour.